HCPCS Code J7627

Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
Code effective Jan 01, 2007

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J7627 is a valid 2026 HCPCS code meaning Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg or (Budesonide comp unit) for short. HCPCS J7627 has been effective since 01/01/2007 and applies to Medical care.

HCPCS Code Details - J7627

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7627
Description

Long description:
Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg

Short description:
Budesonide comp unit

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code D1G - Drugs Administered through DME
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2007
Date added Added Jan 01, 2006

See also

  • HCPCS J7626 · Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg

  • HCPCS J7633 · Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram

  • HCPCS J7634 · Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram

  • HCPCS J7628 · Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.